Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prothena Corp Public (PRTA) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Prothena Corp Public (PRTA) over the last 14 years, with Q3 2025 value amounting to $10000.0.

  • Prothena Corp Public's Capital Expenditures rose 1111.11% to $10000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $181000.0, marking a year-over-year decrease of 8996.67%. This contributed to the annual value of $298000.0 for FY2024, which is 8939.5% down from last year.
  • Prothena Corp Public's Capital Expenditures amounted to $10000.0 in Q3 2025, which was up 1111.11% from $86000.0 recorded in Q2 2025.
  • Prothena Corp Public's 5-year Capital Expenditures high stood at $1.5 million for Q4 2023, and its period low was $9000.0 during Q3 2024.
  • In the last 5 years, Prothena Corp Public's Capital Expenditures had a median value of $116500.0 in 2022 and averaged $238055.6.
  • In the last 5 years, Prothena Corp Public's Capital Expenditures soared by 92582.78% in 2023 and then plummeted by 9796.38% in 2024.
  • Over the past 5 years, Prothena Corp Public's Capital Expenditures (Quarter) stood at $319000.0 in 2021, then plummeted by 52.66% to $151000.0 in 2022, then soared by 925.83% to $1.5 million in 2023, then plummeted by 97.22% to $43000.0 in 2024, then crashed by 76.74% to $10000.0 in 2025.
  • Its Capital Expenditures stands at $10000.0 for Q3 2025, versus $86000.0 for Q2 2025 and $42000.0 for Q1 2025.